Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?

被引：0
|
作者：
Qin, Kirby R. [1 ,2 ,3 ]
Mertens, Eveline [1 ]
Tempo, Jake A. [4 ]
Perera, Marlon [4 ]
Brennan, Janelle [1 ,2 ]
机构：
[1] Bendigo Hlth, Dept Urol, 100 Barnard St, Bendigo, Vic 3550, Australia
[2] Monash Univ, Sch Rural Hlth, Bendigo, Vic, Australia
[3] Monash Univ, Dept Paediat, Melbourne, Vic, Australia
[4] Austin Hlth, Dept Urol, Melbourne, Vic, Australia
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 05期
关键词：
D O I：
10.21037/tau-24-12
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：920 / 922
页数：3
相关论文
共 50 条
  • [1] Fezolinetant in the treatment of vasomotor symptoms associated with menopause
    Depypere, Herman
    Lademacher, Christopher
    Siddiqui, Emad
    Fraser, Graeme L.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 681 - 694
  • [2] Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause
    Roberts, Megan Z.
    Andrus, Miranda R.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (09) : 1131 - 1136
  • [3] Androgen deprivation therapy-associated vasomotor symptoms
    Jones, Jason M.
    Kohli, Manish
    Loprinzi, Charles L.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (02) : 193 - 197
  • [4] Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2024, 40 (05) : 173 - 180
  • [5] Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms
    Bonga, Krishna Nikhila
    Mishra, Archana
    Maiti, Rituparna
    Padhy, Biswa Mohan
    Meher, Bikash Ranjan
    Srinivasan, Anand
    [J]. OBSTETRICS AND GYNECOLOGY, 2024, 143 (03): : 393 - 402
  • [6] Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause A Randomized Controlled Trial
    Neal-Perry, Genevieve
    Cano, Antonio
    Lederman, Samuel
    Nappi, Rossella E.
    Santoro, Nanette
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Valluri, Udaya
    Ottery, Faith D.
    [J]. OBSTETRICS AND GYNECOLOGY, 2023, 141 (04): : 737 - 747
  • [7] Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis
    Chavez, Matheus Pedrotti
    Pasqualotto, Eric
    Ferreira, Rafael Oliva Morgado
    Hohl, Alexandre
    de Moraes, Francisco Cezar Aquino
    Schmidt, Pedro Henrique Siedschlag
    Rodrigues, Anna Luiza Soares de Oliveira
    de Sa, Joao Roberto
    [J]. CLIMACTERIC, 2024, 27 (03) : 245 - 254
  • [8] Phase II study of fezolinetant for treatment of vasomotor symptoms associated with menopause in Japan
    Takamatsu, Kiyoshi
    Miki, Takashi
    Miyazaki, Kentaro
    Hashimoto, Atsuki
    He, Weizhong
    Wang, Xuegong
    [J]. CLIMACTERIC, 2024, 27 (04) : 389 - 397
  • [9] Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause
    Santoro, Nanette
    Johnson, Kimball
    Nappi, Rossella E.
    Neal-Perry, Genevieve
    Shapiro, Marla
    Stute, Petra
    Thurston, Rebecca C.
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Lee, Misun
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 154 - 155
  • [10] Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT
    Johnson, Kimball A.
    Martin, Nancy
    Nappi, Rossella E.
    Neal-Perry, Genevieve
    Shapiro, Marla
    Stute, Petra
    Thurston, Rebecca C.
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Lee, Misun
    Santoro, Nanette
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 1981 - 1997
12345